Fig. 1From: TIMs, TAMs, and PS- antibody targeting: implications for cancer immunotherapyDiagram depicting PS-targeting mAb and β2GP1 binding to PS on a cell surface. Proposed mechanism of PS-targeting mAb binding to exposed PS in a β2GP1-dependent manner. Not drawn to scaleBack to article page